Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys

Journal of Ocular Pharmacology and Therapeutics, Ahead of Print.

Source: Journal of Ocular Pharmacology and Therapeutics - February 17, 2021 Category: Opthalmology Authors: Masahiro Fuwa Atsushi Shimazaki Noriko Odani-Kawabata Tomoko Kirihara Takazumi Taniguchi Ryo Iwamura Kenji Yoneda Masatomo Kato Kenji Morishima Naveed K. Shams Source Type: research